GEN Exclusives

More »

GEN News Highlights

More »
Feb 15, 2011

Dutch Ministry Puts Public Vaccine Production Site up for Sale

  • The Netherlands Ministry of Health, Welfare and Sport has started the process of selling off the vaccine production facilities of its Nederlands Vaccine Institute (NVI) to the private sector. The sale results from the ministry’s 2010 decision to stop the production of vaccines through the public NVI body and integrate the institute’s other tasks into the Dutch National Institute for Public Health and the Environment (RIVM) from the beginning of this year. NVI activities that will be shifted to the RIVM include public vaccine research and development along with vaccine procurement, warehousing, and distribution.

    The NVI production facilities in Bilthoven manufacture bioipharmaceuticals including viral and bacterial vaccines. The Dutch Ministry says contract manufacturing for third parties is within the scope of activities up for sale. Current production activities at the NVI comprise: inactivated polio vaccine as bulk or final product, BCG vaccines used in the post-surgical treatment of bladder cancer, and the combined diphtheria-tetanus-polio vaccine and tetanus toxoid vaccine used for vaccinating children and adults.  


Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Climate Change and Disease

Are the incursions of dengue fever and West Nile virus into North America just the tip of the iceberg of insect-borne diseases that are migrating due to a warming planet?